
Ma Xingtian, former chairman of Kangmei Pharmaceutical, was sentenced to 12 years in prison and fined 1.2 million yuan ($188,300) for manipulating the securities market, failure to disclose important information and bribery.
Court finds drugmaker and auditors responsible for $385m loss to investors
Ma Xingtian, former chairman of Kangmei Pharmaceutical, was sentenced to 12 years in prison and fined 1.2 million yuan ($188,300) for manipulating the securities market, failure to disclose important information and bribery.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.